BB Biotech

مادة اعلانية

Latest Update: 30 Apr 2026 19:30 Abu Dhabi Time.

Market Status: Closed

BBZA

BB Biotech

44.60

EUR

2.800

6.70%

Open

44.60

Prev Close

44.60

PX_VOLUME

231

MARKET CAP (M)

DAY RANGE

44.60 - 44.60

52 WEEKS

28.00 - 49.65

Stock Statistics

Yearly Change

49.41%

Listed Shares (Million)

Earnings Multiple

3.03

Average 30-day trading volume

396.42

Price-to-book ratio

0.92

Earnings Per Share

10.54

Previous Dividend Distribution

1.46

Dividend Yield

5.10%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		-10.09	481.33	454.34	-93.71	-233.41	67.79	-148.49	-77.76	270.70	118.75	-39.04
Gross Profit
Operating Income		-21.36	471.71	447.64	-100.22	-240.86	60.43	-155.95	-85.49	261.95	110.73	-46.71
Net Income		-21.38	471.68	447.62	-100.24	-240.93	59.66	-157.17	-87.08	260.49	109.12	-48.39
Profit Margin		211.78	98.00	98.52	106.97	103.22	88.00	105.85	111.98	96.23	91.89	123.97

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		608.55	112.24	-166.08	-313.00	-344.55	739.93
Gross Profit
Operating Income		578.25	80.93	-200.73	-356.02	-403.76	692.13
Net Income		578.13	75.90	-206.61	-357.81	-404.81	691.17
Profit Margin		95.00	67.62	124.40	114.32	117.49	93.41

Balance Sheet

	Period Ending:	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		2,641.18	2,785.76	2,310.76	1,844.91	1,948.87	2,407.40	2,506.19	2,709.42	2,828.01	2,637.15	2,520.74
Total Liabilities		7.86	6.97	3.66	2.43	4.42	121.11	277.23	322.49	353.99	313.94	306.64
Total Equity		2,633.32	2,778.78	2,307.10	1,842.48	1,944.45	2,286.29	2,228.96	2,386.94	2,474.02	2,323.22	2,214.10

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		2,785.76	2,407.40	2,637.15	3,053.39	3,644.08	3,963.14
Total Liabilities		6.97	121.11	313.94	367.25	360.59	75.59
Total Equity		2,778.78	2,286.29	2,323.22	2,686.14	3,283.49	3,887.55

Cash Flows Statements

	Period Ending:	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		373.71	16.14	63.81	-59.96	289.10	156.68	47.88	25.21	69.81	-2.51	5.72
Cash From Investing Activities
Cash From Financing Activities		-124.09	0.00	17.00	-2.22	-217.92	-159.12	-45.91	-25.30	-69.89	2.80	-6.40
Net Change in Cash		256.76	16.28	79.78	-68.02	69.72	-1.79	1.93	-0.09	-0.10	0.18	-0.58

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		309.09	299.58	212.47	229.40	-95.77	261.57
Cash From Investing Activities
Cash From Financing Activities		-203.14	-300.22	-214.41	-231.54	92.75	-283.60
Net Change in Cash		97.76	-0.04	-1.45	-0.89	-3.98	-23.89

* In Million of Euro Member Countries

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.